Back to search results

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Solid Tumors

Locations
  • Investigative Site US058, Birmingham, Alabama, United States
  • Investigative Site US016, Anchorage, Alaska, United States
  • Investigative Site US026, Chandler, Arizona, United States
  • Investigative Site US045, Tucson, Arizona, United States
  • Investigative Site US051, Duarte, California, United States
  • Investigative Site US048, Fountain Valley, California, United States
  • Investigative Site US049, Irvine, California, United States
  • Investigative Site US054, La Jolla, California, United States
  • Investigative Site US027, Los Angeles, California, United States
  • Investigative Site US036, Los Angeles, California, United States
  • Investigative Site US019, Los Angeles, California, United States
  • Investigative Site US034, San Francisco, California, United States
  • Investigative Site US001, Santa Monica, California, United States
  • Investigative Site US071, Denver, Colorado, United States
  • Investigative Site US013, Washington D.C., District of Columbia, United States
  • Investigative Site US046, Washington D.C., District of Columbia, United States
  • Investigative Site US072, Fort Myers, Florida, United States
  • Investigative Site US075, Miami, Florida, United States
  • Investigative Site US073, West Palm Beach, Florida, United States
  • Investigative Site US074, Winter Park, Florida, United States
  • Investigative Site US023, Atlanta, Georgia, United States
  • Investigative Site US079, Chicago, Illinois, United States
  • Investigative Site US030, Evanston, Illinois, United States
  • Investigative Site US005, Naperville, Illinois, United States
  • Investigative Site US009, Springfield, Illinois, United States
  • Investigative Site US021, Indianapolis, Indiana, United States
  • Investigative Site US007, New Orleans, Louisiana, United States
  • Investigative Site US022, Boston, Massachusetts, United States
  • Investigative Site US006, Ann Arbor, Michigan, United States
  • Investigative Site US010, Detroit, Michigan, United States
  • Investigative Site US078, Grand Rapids, Michigan, United States
  • Investigative Site US012, Ypsilanti, Michigan, United States
  • Investigative Site US066, Maple Grove, Minnesota, United States
  • Investigative Site US047, Hattiesburg, Mississippi, United States
  • Investigative Site US077, Hackensack, New Jersey, United States
  • Investigative Site US017, Morristown, New Jersey, United States
  • Investigative Site US059, Lake Success, New York, United States
  • Investigative Site US031, New York, New York, United States
  • Investigative Site US041, New York, New York, United States
  • Investigative Site US004, New York, New York, United States
  • Investigative Site US003, New York, New York, United States
  • Investigative Site US029, The Bronx, New York, United States
  • Investigative Site US035, Chapel Hill, North Carolina, United States
  • Investigative Site US050, Cleveland, Ohio, United States
  • Investigative Site US020, Cleveland, Ohio, United States
  • Investigative Site US033, Columbus, Ohio, United States
  • Investigative Site US042, Portland, Oregon, United States
  • Investigative Site US008, Philadelphia, Pennsylvania, United States
  • Investigative Site US043, Philadelphia, Pennsylvania, United States
  • Investigative Site US056, Pittsburgh, Pennsylvania, United States
  • Investigative Site US055, Sioux Falls, South Dakota, United States
  • Investigative Site US039, Nashville, Tennessee, United States
  • Investigative Site US060, Nashville, Tennessee, United States
  • Investigative Site US070, Nashville, Tennessee, United States
  • Investigative Site US067, Dallas, Texas, United States
  • Investigative Site US062, Denison, Texas, United States
  • Investigative Site US011, Houston, Texas, United States
  • Investigative Site US018, Houston, Texas, United States
  • Investigative Site US063, San Antonio, Texas, United States
  • Investigative Site US053, Salt Lake City, Utah, United States
  • Investigative Site US076, Charlottesville, Virginia, United States
  • Investigative Site US057, Fairfax, Virginia, United States
  • Investigative Site US065, Fairfax, Virginia, United States
  • Investigative Site US064, Salem, Virginia, United States
  • Investigative Site US032, Seattle, Washington, United States
  • Investigative Site US044, Madison, Wisconsin, United States
  • Investigative Site AU007, Liverpool, New South Wales, Australia
  • Investigative Site AU003, Wollongong, New South Wales, Australia
  • Investigative Site AU006, Woodville South, South Australia, Australia
  • Investigative Site AU005, Box Hill, Victoria, Australia
  • Investigative Site AU004, Melbourne, Victoria, Australia
  • Investigative Site AU001, Melbourne, Victoria, Australia
  • Investigative Site AU002, Canberra, Australia
  • Investigative Site AU008, Perth, Australia
  • Investigative Site AT002, Innsbruck, Austria
  • Investigative Site AT004, Linz, Austria
  • Investigative Site AT003, Salzburg, Austria
  • Investigative Site AT001, Vienna, Austria
  • Investigative Site BE008, Anderlecht, Belgium
  • Investigative Site BE003, Brussels, Belgium
  • Investigative Site BE009, Brussels, Belgium
  • Investigative Site BE001, Edegem, Belgium
  • Investigative Site BE005, Ghent, Belgium
  • Investigative Site BE007, Gilly, Belgium
  • Investigative Site BE004, Leuven, Belgium
  • Investigative Site BE006, Liège, Belgium
  • Investigative Site BE002, Yvoir, Belgium
  • Investigative Site CA001, Toronto, Ontario, Canada
  • Investigative Site CA005, Laval, Quebec, Canada
  • Investigative Site CA006, Montreal, Quebec, Canada
  • Investigative Site CA004, Québec, Quebec, Canada
  • Investigative Site DK006, Aalborg, Denmark
  • Investigative Site DK005, Århus N, Denmark
  • Investigative Site DK001, Herlev, Denmark
  • Investigative Site DK004, Odense C, Denmark
  • Investigative Site DK003, Roskilde, Denmark
  • Investigative Site DK002, Vejle, Denmark
  • Investigative Site FI001, Helsinki, Finland
  • Investigative Site FI003, Tampere, Finland
  • Investigative Site FI002, Turku, Finland
  • Investigative Site FR013, Brest, France
  • Investigative Site FR012, Chambray-lès-Tours, France
  • Investigative Site FR014, Dijon, France
  • Investigative Site FR002, Lille, France
  • Investigative Site FR011, Lyon, France
  • Investigative Site FR016, Lyon, France
  • Investigative Site FR006, Marseille, France
  • Investigative Site FR015, Montpellier, France
  • Investigative Site FR003, Paris, France
  • Investigative Site FR009, Paris, France
  • Investigative Site FR004, Pessac, France
  • Investigative Site FR008, Poitiers, France
  • Investigative Site FR010, Reims, France
  • Investigative Site FR005, Rennes, France
  • Investigative Site FR007, Toulouse, France
  • Investigative Site FR001, Villejuif, France
  • Investigative Site DE018, Berlin, Germany
  • Investigative Site DE020, Berlin, Germany
  • Investigative Site DE003, Bochum, Germany
  • Investigative Site DE019, Bonn, Germany
  • Investigative Site DE008, Cologne, Germany
  • Investigative Site DE001, Dresden, Germany
  • Investigative Site DE013, Düsseldorf, Germany
  • Investigative Site DE004, Essen, Germany
  • Investigative Site DE005, Frankfurt, Germany
  • Investigative Site DE016, Freiburg im Breisgau, Germany
  • Investigative Site DE017, Göttingen, Germany
  • Investigative Site DE002, Halle, Germany
  • Investigative Site DE007, Hamburg, Germany
  • Investigative Site DE006, Hamburg, Germany
  • Investigative Site DE009, Leipzig, Germany
  • Investigative Site DE015, Munich, Germany
  • Investigative Site DE014, München, Germany
  • Investigative Site DE010, Nuremberg, Germany
  • Investigative Site DE011, Ulm, Germany
  • Investigative Site IT002, Bologna, Italy
  • Investigative Site IT010, Brescia, Italy
  • Investigative Site IT009, Candiolo, Italy
  • Investigative Site IT012, Foggia, Italy
  • Investigative Site IT006, Milan, Italy
  • Investigative Site IT008, Milan, Italy
  • Investigative Site IT011, Naples, Italy
  • Investigative Site IT003, Pisa, Italy
  • Investigative Site IT004, Roma, Italy
  • Investigative Site IT005, Rome, Italy
  • Investigative Site IT001, Rozzano, Italy
  • Investigative Site IT007, Verona, Italy
  • Investigative Site JP002, Kashiwa-shi, Japan
  • Investigative Site JP003, Kōtoku, Japan
  • Investigative Site JP007, Mitaka-shi, Japan
  • Investigative Site JP004, Osaka, Japan
  • Investigative Site JP006, Toyama, Japan
  • Investigative Site JP001, Yokohama, Japan
  • Investigative Site NL001, Amsterdam, Netherlands
  • Investigative Site NL007, Eindhoven, Netherlands
  • Investigative Site NL005, Groningen, Netherlands
  • Investigative Site NL003, Maastricht, Netherlands
  • Investigative Site NL006, Nieuwegein, Netherlands
  • Investigative Site NO002, Bergen, Norway
  • Investigative Site NO001, Oslo, Norway
  • Investigative Site NO005, Stavanger, Norway
  • Investigative Site NO003, Trondheim, Norway
  • Investigative Site PL008, Gdansk, Poland
  • Investigative Site PL003, Krakow, Poland
  • Investigative Site PL007, Warsaw, Poland
  • Investigative Site PL002, Warsaw, Poland
  • Investigative Site PL001, Warsaw, Poland
  • Investigative Site PL004, Wroclaw, Poland
  • Investigative Site PR001, Dorado, Puerto Rico
  • Investigative Site KR004, Goyang-si, South Korea
  • Investigative Site KR005, Seongnam, South Korea
  • Investigative Site KR007, Seongnam-si, South Korea
  • Investigative Site KR002, Seoul, South Korea
  • Investigative Site KR006, Seoul, South Korea
  • Investigative Site KR001, Seoul, South Korea
  • Investigative Site KR003, Seoul, South Korea
  • Investigative Site KR008, Seoul, South Korea
  • Investigative Site ES011, Badalona, Spain
  • Investigative Site ES003, Barcelona, Spain
  • Investigative Site ES002, Barcelona, Spain
  • Investigative Site ES014, Las Palmas de Gran Canaria, Spain
  • Investigative Site ES016, Madrid, Spain
  • Investigative Site ES006, Madrid, Spain
  • Investigative Site ES007, Madrid, Spain
  • Investigative Site ES012, Madrid, Spain
  • Investigative Site ES008, Madrid, Spain
  • Investigative Site ES013, Madrid, Spain
  • Investigative Site ES005, Palma de Mallorca, Spain
  • Investigative Site ES009, Santander, Spain
  • Investigative Site ES010, Seville, Spain
  • Investigative Site ES015, Valencia, Spain
  • Investigative Site ES017, Valencia, Spain
  • Investigative Site ES001, Valencia, Spain
  • Investigative Site ES004, Zaragoza, Spain
  • Investigative Site SE003, Linköping, Sweden
  • Investigative Site SE001, Malmo, Sweden
  • Investigative Site SE002, Solna, Sweden
  • Investigative Site CH005, Basel, Switzerland
  • Investigative Site CH003, Bern, Switzerland
  • Investigative Site CH004, Geneva, Switzerland
  • Investigative Site CH002, Lausanne, Switzerland
  • Investigative Site CH001, Zurich, Switzerland
  • Investigative Site GB008, Dundee, United Kingdom
  • Investigative Site GB011, Guildford, United Kingdom
  • Investigative Site GB002, Headington, United Kingdom
  • Investigative Site GB001, Leeds, United Kingdom
  • Investigative Site GB009, London, United Kingdom
  • Investigative Site GB004, London, United Kingdom
  • Investigative Site GB003, Manchester, United Kingdom
  • Investigative Site GB006, Metropolitan Borough of Wirral, United Kingdom
  • Investigative Site GB010, Northwood, United Kingdom
  • Investigative Site GB005, Norwich, United Kingdom
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)